MetaCap

Haemonetics Statistics

NYSE: HAEHealth CareMedical/Dental InstrumentsUSD

120.16-0.21 (-0.17%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Haemonetics by the numbers

Haemonetics has a market capitalization of $5.47 billion based on 45.54M shares outstanding. Its trailing P/E ratio is 53.2, above the 6-company peer median of 50.6, and its forward P/E is 19.2. The stock trades 4.3% above its 50-day average and 45.4% above its 200-day average.

Average daily trading volume is 659.70K shares, or about $79.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

HAE valuation vs. peer median

HAE compared with the median of 8 peer companies
MetricHAEPeer medianDifference
Market cap$5.47B$4.29B+27%
P/E (TTM)53.250.6+5%
Forward P/E19.217.9+7%
Avg. volume659.70K723.55K-9%

Peer median across 8 companies: MMSI, TFX, MMED, ICUI, STVN, HTFL, NVST, PLSE.

Valuation

Price / sales (latest FY)
4.10

Price and trading

Previous close
120.37
Open
120.37
Day range
119.68 – 122.00
52-week range
51.00 – 132.00
52-week change
+52.51%
Beta
—
Volume
382.95K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
5.47B
Pe
53.17
Forward Pe
19.17
Eps
2.26
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
132.00
Week52 Low
51.00
Avg Volume
659.70K
Shares Outstanding
45.54M
Ma50
115.17
Ma200
82.65
Earnings Date
Nov 5, 2026
Pct From52w High
-8.97%
Pct From52w Low
135.61%

Related